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Abstract CD44 appears to be involved in signal transduction,
however, the mechanism of this function is unclear. Protein
kinase activity was detected in neutrophils associated with CD44.
Most of the protein kinase activity associated with these antigens
was tyrosine kinase activity. Src family kinases lyn and hck were
found to account for much of the associated tyrosine kinase
activity. The data suggest that associated tyrosine kinase activity
may play a role in signal transduction from CD44 in neutrophils
to regulate other cell functions.
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1. Introduction
CD44, also known as Pgp-1 and Hermes, is a type I trans-
membrane protein, expressed as a family of isoforms gener-
ated by alternative RNA splicing and post-translational mod-
i¢cations, on a variety of cells [1]. CD44 binds hyaluronic acid
and osteopontin [2], and appears to play a role in in£amma-
tion, leukocyte adhesion and homing, including adhesion to
endothelial cells and homophilic leukocyte aggregation, and is
also capable of signaling, resulting in T-cell activation [1,3^9].
In addition, CD44 may play a role in metastasis, since CD44
expression is associated with metastatic potential in a variety
of malignancies [1,8^14].
The mechanism of signaling via CD44 is unclear [1,15].
Protein phosphorylation is an important mechanism of regu-
lating protein function, and CD44 has potential serine phos-
phorylation sites in its intracellular domain and is constitu-
tively phosphorylated [1,15]. In addition, recent studies have
suggested that CD44 may be associated with the tyrosine ki-
nase lck, and signal via phosphorylation pathways in T-cells
[16]. When CD44 was immunoprecipitated from solubilized
neutrophils, protein tyrosine kinase activity associated with
this antigen was detected in the immunoprecipitates. The src
family kinases lyn and hck were found to account for much of
this activity. The data suggest that tyrosine kinase activity
associated with CD44 may play a role in the transduction
of regulatory signals in neutrophils.
2. Materials and methods
2.1. Cell preparation
Neutrophils were prepared from heparinized (2 units/ml) human
venous blood as described [17] and were suspended at the indicated
concentrations in 145 mM NaCl, 20 mM HEPES (Gibco, Grand
Island, NY, USA), pH 7.3 (NaCl-HEPES). Di¡erential cell counts
on Wright-stained cells routinely revealed greater than 95% neutro-
phils. Viability as assessed by trypan blue dye exclusion was greater
than 98%.
2.2. Antibodies and reagents
mAb AHN-12 (IgG1) (CD45) has been previously described [18].
CD44 mAbs were obtained from the Fifth International Workshop
and Conference on Human Leukocyte Di¡erentiation Antigens in-
cluding the following CD44 mAbs: CD44-6B6, CD44-9F5, A3D8,
HP2/9, BRIC214, and 212.3, as was the CD66de mAb COL-1. The
T-cell reactive mAbs 5T-0111 (MEM-24) (IgG1) and 5T-012 (263K
3F4) (IgG2a) were obtained from the T-cell panel of the same Work-
shop. AHN-17 (IgG1) and AHN-17.1 (IgG1) recognize migration in-
hibitory related protein -8 and -14, and were described in the same
Workshop. Polyclonal antibodies to yes, src, lck, lyn, fyn, hck, and fgr
were obtained from Santa Cruz Biotechnology, Santa Cruz, CA,
USA. Polyclonal antibodies to yes, fyn, src, and fgr were also ob-
tained as a gift from Dr. F. Uckun, University of Minnesota Medical
School, Minneapolis, MN, USA. Antiserum to syk was purchased
from Upstate Biotechnology (Lake Placid, NY, USA). Normal mouse
serum (NMS) and normal rat serum (NRS) were purchased from
Sigma (St. Louis, MO, USA).
2.3. Immunoprecipitation and PAGE
Immunoprecipitation was performed as previously described with
minor modi¢cations [19,20]. Brie£y, 2U107 cells were suspended in
1.1 ml of Brij solubilization bu¡er (20 mM Tris-HCl, pH 8.2, 150 mM
NaCl, 1 mM PMSF, 2 mM MgCl2, 0.02% NaN3, and 1.0% Brij 58
(Pierce)), and incubated on ice for 15 min. The suspensions were then
centrifuged at 9800Ug for 15 min at 4‡C. The resulting supernatants
were used for immunoprecipitation or analyzed by SDS-PAGE di-
rectly.
For immunoprecipitations, 1 ml of 10% Staphylococcus aureus
(Pansorbin A, Calbiochem, La Jolla, CA, USA) was mixed with 100
Wl of rabbit anti-mouse IgGHL (Organon Teknika, Westchester, PA,
USA), and the mixture was incubated at 4‡C for 1 h. One ml of bu¡er
A (1 mg/ml BSA, 0.05% NP-40, 20 mM Tris-HCl, pH 7.6, 100 mM
NaCl, 1 mM EDTA, 0.05% NaN3) was added and the Pansorbin A-
antibody complex was recovered by centrifuging at 2000Ug for 10
min at 4‡C and resuspended in 390 Wl of bu¡er A and 40 Wl of ascites
containing the indicated mAb, or normal mouse serum (NMS) was
added, and the mixtures were incubated for 2 h at 4‡C. The Pansorbin
A-antibody complex was recovered by centrifuging at 2000Ug for 10
min at 4‡C, washed once with 1 ml of bu¡er A, and resuspended in
1 ml of Brij-SA bu¡er (1 mg/ml BSA, 0.05% Brij 58, 20 mM Tris-HCl,
pH 7.6, 100 mM NaCl, 1 mM EDTA, 0.05% NaN3). Cell proteins
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were then immunoprecipitated in reaction mixtures containing the
neutrophil extract, Pansorbin A-bound antibody complex, 0.5% Brij
58, 1 mg/ml BSA, 20 mM Tris-HCl, pH 8.2, 150 mM NaCl, 2 mM
MgCl2, 0.125 mg/ml gelatin, and 1 mM PMSF, in a total volume of
approximately 300 Wl in 10U75 mm glass tubes. After 1 h at 4‡C, the
mixture was washed three times by adding 1 ml of Brij-wash bu¡er
(20 mM Tris-HCl, pH 8.2, 150 mM NaCl, 1 mg/ml BSA, 0.5% Brij 58,
2 mM MgCl2, 0.125 mg/ml gelatin, 1 mM PMSF, and 0.02% NaN3),
and centrifuging at 2000Ug for 12 min at 4‡C. The pellet was then
suspended in 1 ml of NaCl-HEPES, transferred to a 1.5-ml Eppendorf
tube and pelleted at 9800Ug for 10 min at 4‡C.
2.4. Protein kinase assay
Protein kinase activity was detected as previously described [20].
Brie£y, immunoprecipitates were suspended in 30 Wl of NaCl-HEPES.
Thirty Wl of labeling bu¡er (NaCl-HEPES, 0.1% Brij 58, 6 mM
MnCl2, 40 mM MgCl2, 200 WM Na3VO4, 200 WM Na2MoO4, and
10 WCi of [Q-32P]ATP (sp. act. 4500 Ci/mmol, ICN, Irvine, CA, USA)
was then added, and the mixtures were incubated for 10 min at 23‡C.
The reaction was stopped by adding 4U Laemmli sample bu¡er con-
taining 400 WM ATP, incubated at 100‡C for 2 min, and analyzed by
SDS-PAGE [21]. Molecular weight standards were purchased from
Sigma. Gel slabs were stained, dried, and subjected to autoradiogra-
phy by using Dupont Cronex ¢lm.
2.5. Identi¢cation of speci¢c tyrosine kinases
To identify speci¢c tyrosine kinases associated with CD44, neutro-
phils were solubilized in Brij solubilization bu¡er, immunoprecipitated
with the indicated mAb, and the immunoprecipitates were radiola-
beled with [Q-32P]ATP as described above, and 32P-labeled proteins
were reimmunoprecipitated as previously described [20]. Brie£y, the
precipitate was washed once with 600 Wl of NaCl-HEPES containing
1 mM Na3VO4, 1 mM Na2MoO4; and 400 WM ATP, and centrifuged
at 9800Ug for 5 min at 4‡C. One ml of NaCl-HEPES containing
1 mM Na3VO4, 1 mM Na2MoO4; and 400 WM ATP was added
and the mixture was transferred to a new Eppendorf tube and cen-
trifuged at 9800Ug for 5 min at 4‡C. Four hundred Wl of NaCl-
HEPES containing 1% SDS, 200 WM Na3VO4, and 200 WM
Na2MoO4 was added to the precipitate, and the mixture incubated
at 100‡C for 2 min and then 14 min at 23‡C. The mixture was cen-
trifuged at 13 000Ug for 5 min at 23‡C, and the pellet was incubated
with 200 Wl of NaCl-HEPES containing 1% SDS, 200 WM Na3VO4,
and 200 WM Na2MoO4 for 10 min at 23‡C, and recovered by centri-
fuging at 13 000Ug for 5 min. The supernatants were pooled and
frozen until use. The supernatants were then diluted with NaCl-
HEPES containing 1% NP-40, 200 WM Na3VO4, and 200 WM
Na2MoO4 to 0.1% SDS, and immunoprecipitated as described above
for 1 h in reaction mixtures containing the indicated antibody bound
to 20 Wl of protein A-agarose beads (Sigma), and washed four times as
described above, except that the beads were centrifuged at 400Ug for
5 min at 4‡C, and the wash bu¡er consisted of 20 mM Tris-HCl, pH
8.2, 150 mM NaCl, 1 mg/ml BSA, 0.5% NP-40, 2 mM MgCl2,
0.125 mg/ml gelatin, 1 mM Na3VO4, 1 mM Na2MoO4; 1 mM
PMSF, and 0.02% NaN3. The resulting immunoprecipitate was ana-
lyzed by SDS-PAGE and autoradiography as described above.
2.6. Phosphoamino acid analysis
Phosphoamino acid analyses were performed as previously de-
scribed [20,22]. Brie£y, radiolabeled proteins resolved by SDS-
PAGE were transblotted onto Immobilon-P (PVDF) paper (Milli-
pore, Bedford, MA, USA), localized by autoradiography, and excised.
The proteins on the PVDF were then hydrolyzed in vacuo in con-
stantly boiling 6 M HCl for 2 h at 110‡C. The HCl was removed by
evaporation using a SpeedVac (Savant Instruments). The dried, par-
tially hydrolyzed samples were then dissolved in water containing
phosphoserine (P-S), phosphothreonine (P-T), and phosphotyrosine
(P-Y) (Sigma) each at 1 mg/ml. The samples were then spotted on
aluminum sheets precoated with silica gel (0.2 mm layer thickness, 11
cm height, Merck Laboratories, EM Science, Gibbstown, NJ, USA)
and resolved by one-dimensional thin layer chromatography in etha-
nol/25% NH4OH (3.5:1.6). The chromatography cycle was repeated
three times to achieve optimal separation. Between cycles, plates were
air dried followed by chromatography in the same solvent. The radio-
labeled phosphoamino acids were detected by autoradiography using
X-Omat AR ¢lm.
3. Results
3.1. Identi¢cation of protein kinase activity associated with
CD44
To determine if protein kinase activity was present in the
material immunoprecipitated by CD44 mAbs, we analyzed
immunoprecipitates from unlabeled neutrophils for their abil-
ity to incorporate [Q-32P]ATP into precipitated proteins as
described in Section 2. When neutrophils were solubilized as
described in Section 2, protein kinase activity was detected in
the material immunoprecipitated by CD44 mAbs (Fig. 1).
When [Q-32P]ATP was added to the material immunoprecipi-
tated by the CD44 mAb CD44-6B6 (Fig. 1, lane 3) or any of
¢ve other CD44 mAbs (CD44-9F5, A3D8, HP2/9, BRIC214,
and 212.3, not shown), 32P was incorporated into at least four
distinct proteins of V100^108, 64, 55^60, and 50^52 kDa,
that were not present when material was immunoprecipitated
by NMS (lane 1), the T-cell reactive mAb 5T-012 (lane 2), or
the T-cell reactive mAb 5T-011, the CD45 mAb AHN-12, the
CD66de mAb COL-1, or mAbs AHN-17 or AHN-17.1 (not
shown).
Each of the four individual 32P-labeled proteins identi¢ed in
the CD44 immunoprecipitate shown in Fig. 1 were excised
from the gel and examined for phosphoamino acid content.
Phosphoamino acid analyses of these proteins revealed that
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Fig. 1. Co-immunoprecipitation of protein kinases with CD44. Neu-
trophils were solubilized in Brij solubilization bu¡er and immuno-
precipitated with the indicated antibody, and the immunoprecipi-
tates were then incubated with [Q-32P]ATP as described in the text.
The resulting phosphoproteins were resolved by SDS-PAGE and
visualized by autoradiography. Immunoprecipitating antibodies:
NMS (lane 1), the T-cell reactive mAb 5T-011 (lane 2), and the
CD44 mAb CD44-6B6 (lane 3). The numbers at the right indicate
the bands subjected to phosphoamino acid analysis. Proteins used
as molecular weight standards were: myosin heavy chain, 200 000;
Escherichia coli L-galactosidase, 116 000; phosphorylase a, 97 400;
bovine serum albumin, 66 000; and ovalbumin, 45 000. A duplicate
experiment gave similar results.
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the majority of radiolabel in each of these four proteins was
present on tyrosine, demonstrating the presence of tyrosine
kinase activity (Fig. 2, lanes 1^4).
3.2. Identi¢cation of tyrosine kinases associated with CD44
As expected, several src family kinases, including yes, src,
lyn, hck, fgr, and syk, were detected in neutrophils [17]. To
identify the tyrosine kinases coprecipitated with CD44, reim-
munoprecipitation with antisera to speci¢c tyrosine kinases
was employed. The associated kinase assay was performed
as in Fig. 1, and the 32P-labeled proteins were dissociated
from the immune complexes and reimmunoprecipitated with
antisera to speci¢c tyrosine kinases as described in Section 2
(Fig. 3). Reimmunoprecipitation of 32P-labeled proteins gen-
erated from immunoprecipitates with the CD44 mAb CD44-
6B6 demonstrated the presence of lyn (Fig. 3, lane D) and hck
(lane G). No 32P-labeled proteins were detected in the immu-
noprecipitates with normal rat serum (NRS) (lane A), or anti-
sera to yes (lane B), fyn (lane C), src (lane F), or syk (lane H).
32P-labeled proteins were immunoprecipitated by antisera to
fgr (lane E), however, preclearing experiments demonstrated
that these 32P-labeled proteins were lyn and hck, re£ecting
some cross-reactivity of the anti-fgr antisera (not shown).
3.3. Activation of lyn and hck by CD44 antibodies
To determine if CD44 antibody binding to the neutrophil
surface could alter the activity of lyn and hck, cells were
incubated with the CD44 mAb, CD44-6B6, or NMS for 15
min at 37‡C in HBSS, and either solubilized, or incubated
another 15 min in the presence of anti-mouse IgG and then
solubilized, in cell solubilization bu¡er. The solubilized cell
extracts were then immunoprecipitated with antibodies to
lyn and hck as described above, and the kinase activity
present in the immunoprecipitate was assayed by radiolabel-
ing with [Q-32P]ATP as described above. No alteration in the
kinase activity of lyn or hck following incubation with the
mAb was detected (not shown).
4. Discussion
CD44 appears to function directly as a cell adhesion mol-
ecule, but also seems to be capable of transmitting an activa-
tion signal that regulates cellular function [1^9,15]. While the
details of the ‘activation signal’ transmitted by CD44 are not
known, the ¢ndings reported here suggest that protein kinase
activity associated with CD44 may play a role in the signal
transduction process in neutrophils. Taher et al. recently re-
ported that ligation of CD44 by CD44 mAbs in T-cells trans-
duces signals that result in tyrosine phosphorylation of several
intracellular proteins, including ZAP-70 [16]. In addition,
cross-linking CD44 induced an increase in kinase activity of
lck, and lck was associated with CD44 in T-cells, suggesting
that lck is involved in CD44 mediated signaling [16]. In a
separate study, both fyn and lck were found to be associated
with CD44 in T-cells [23].
CD44 has been identi¢ed as a major membrane binding
partner for ERM (ezrin/radixin/moesin) proteins, and ERM
family members are felt to be involved in the association of
actin ¢laments with the plasma membrane [24^26]. The for-
mation of CD44/ERM complexes, implicated in actin ¢lament
reorganization, appears to be regulated in part by the Rho
family of small G proteins and phosphatidylinositol turnover
[24,25,27].
It is of interest that tyrosine kinase activity, including lyn
and hck, were found associated with CD44 in human neutro-
phils. It was not possible to determine if fgr was also associ-
ated due to cross reactivity of the fgr antibodies with lyn and
hck. Neutrophils contain several other src family kinases [17]
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Fig. 3. Immunoprecipitation of tyrosine kinases associated with
CD44. Neutrophils were solubilized in Brij solubilization bu¡er, im-
munoprecipitated with the CD44 mAb CD44-6B6, and the immuno-
precipitates were incubated with [Q-32P]ATP as described in the text
and Fig. 1. The immunoprecipitates were then incubated at 100‡C
for 2 min in a bu¡er containing 1% SDS, cooled to 23‡C, and the
supernatant diluted to 0.1% SDS as described in the text. These ex-
tracts were then immunoprecipitated with NRS (lane A), yes (lane
B), fyn (lane C), lyn (lane D), fgr (lane E), src (lane F), hck (lane
G), or syk (lane H), and analyzed by SDS-PAGE and autoradiogra-
phy as described in the text.
Fig. 2. Phosphoamino acid analysis of proteins co-precipitated by
CD44 mAbs and labeled in an in vitro kinase assay. Neutrophils
were solubilized in Brij solubilization bu¡er and immunoprecipitated
with the CD44 mAb CD44-6B6 (right) as described in Fig. 1, and
the immunoprecipitates were incubated with [Q-32P]ATP. The result-
ing phosphoproteins were resolved by SDS-PAGE as in Fig. 1,
transferred to Immobilon, visualized by autoradiography, excised,
subjected to acid hydrolysis, and the resultant phosphoamino acids
resolved by thin layer chromatography, and visualized by autora-
diography as described in the text. The lane numbers correspond to
the phosphoproteins numbered in Fig. 1 (lane 1: V100^108 kDa;
lane 2: V64 kDa; lane 3: V55^60 kDa; lane 4: V50^52 kDa).
The positions of migration of authentic phosphoserine (P-S), phos-
phothreonine (P-T), and phosphotyrosine (P-Y) are indicated by
dotted lines.
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that were not found associated with CD44. Src kinases have
been found to form complexes with several receptors in other
cells, including CD50, CD63, and CD66 in neutrophils
[17,20,28], and several glycosyl-phosphatidylinositol-anchored
proteins in other cells [29]. Protein kinase C was found to be
associated with CD44 in murine T-cell lymphoma cells, and
may also play a role in cell signaling [15], and some data
suggest that phosphorylation of serine in the cytoplasmic do-
main of CD44 is involved in outside-in signaling [30]. Tyro-
sine kinase activity associated with CD44 may be involved in
signal transduction in neutrophils.
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